Showing results (481-490 of 610) with videos related to
Sort By:
Pageof 61
Cell Reports|August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumabShirin Soleimani, Xuan Li, Ben X Wang, et al.International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancerThomas J Pugh, Mark F Munsell, Seungtaek Choi, et al.The Oncologist|April 6, 2022
"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome ManagementSalma Shickh, Leslie E Oldfield, Marc Clausen, et al.Nature Communications|August 5, 2017
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomasSameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al.American Journal of Human Genetics|October 6, 2023
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsyKirsten M Farncombe, Derek Wong, Maia L Norman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.Nature Communications|February 6, 2024
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patientScott C Lien, Dalam Ly, S Y Cindy Yang, et al.JAMA Network Open|June 5, 2026
Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in InfantsAnne-Marie Rick, Jennifer Deese, Jessica E Kerr, et al.American Journal of Obstetrics and Gynecology|June 22, 2019
Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth StudiesJulio Mateus, Roger B Newman, Cuilin Zhang, et al.Plos Genetics|August 6, 2016
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma DevelopmentKrinio Giannikou, Izabela A Malinowska, Trevor J Pugh, et al.Pageof 61